SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investors monitor ongoing buyout speculation involving biotech firms like Sellas Life Sciences and Inhibrx, while the market reacts to news of successful Phase 3 trial data for its sacituzumab tirumotecan lung cancer treatment. The community is actively debating Merck's strategic needs to address the impending Keytruda patent cliff through potential platform acquisitions and combination therapies.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending as investors monitor the company's aggressive restructuring, including significant job cuts and the development of in-house AI tools designed to reduce reliance on legacy software vendors. The community remains divided between those betting on a long-term turnaround strategy to streamline operations and those skeptical of the company's ability to maintain growth against rising competition and shifting consumer habits.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors rotate into the healthcare sector, fueled by consistent GLP-1 momentum and a diversified pipeline following recent M&A activity. Community discussion is heavily focused on the company's long-term dominance in metabolic health and its strategic moves to secure manufacturing capacity, with many viewing dips as buying opportunities.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver is trending as traders speculate on a potential short squeeze fueled by tight physical supply and COMEX inventory concerns. Investors are closely monitoring the interplay between geopolitical events and currency fluctuations, with many debating whether the current volatility represents a buying opportunity or further downside risk.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is at the center of investor discussions as the critical foundry bottleneck for the accelerating AI infrastructure buildout. Market focus remains locked on the stock as the company manages record-high demand, with community debates centering on whether its strategic foundry dominance or ongoing geopolitical risk and foundry capacity competition define its long-term trajectory.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML remains a central focal point for investors as the semiconductor industry faces a massive, long-term supply crunch for advanced chip manufacturing equipment. The community is actively debating the company's valuation against its indispensable role in the AI buildout, particularly with major upcoming earnings and infrastructure projects expected to reinforce its long-term market dominance.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap is trending as the community expresses significant optimism surrounding a governance proposal to activate the protocol's fee switch and initiate a massive token burn, which many believe will create a deflationary supply shock. Traders are closely monitoring this potential revenue-sharing shift, viewing it as a catalyst for institutional interest and long-term value appreciation.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest monumental Phase 3 clinical data showing its RAS-inhibitor, daraxonrasib, significantly improves overall survival in metastatic pancreatic cancer. The community is actively discussing the stock's massive valuation surge and its potential as a prime M&A target for Big Pharma, especially as the company navigates the pathway toward expedited regulatory approval.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is drawing intense community speculation regarding a potential buyout as institutional interest and speculative volume surges around the stock. While management emphasizes an independent long-term growth strategy for Rezdiffra, investors remain sharply divided over high operational spending versus the significant market opportunity in the evolving MASH treatment landscape.

dogwifhat (WIF) is a Solana-based memecoin featuring a Shiba Inu dog wearing a pink knitted hat that has become a central figure in the 2024-2026 market. Originally launched anonymously in late 2023, the project operates on a decentralized, community-driven model with no formal venture capital backing or complex tokenomics. It represents a cultural phenomenon on the Solana blockchain that celebrates whimsy and simplicity over technical complexity, focusing on its identity as a playful mascot for the digital finance era. The project’s main value proposition is its "Pure Meme Identity," as it maintains a strict focus on its meme origins without forced utility or a pivot toward DeFi and gaming.  The project embodies the community-driven nature of the Solana ecosystem, prioritizing "vibes" and meme-sharing as its primary growth drivers. It follows a "hat stays on" philosophy, maintaining a singular focus on its core meme rather than building a complex ecosystem. While the project does not have a formal governance structure or DAO, decisions are largely driven by social consensus among the community and key influencers. Notable community initiatives include the "Sphere Wif Hat" campaign, which raised nearly $700,000 in USDC in March 2024 to put the mascot on the Las Vegas Sphere. However, after a year of negotiations and delays, organizers officially abandoned the advertisement on March 31, 2025, and initiated a full refund process for donors.  The initial team behind dogwifhat remains anonymous, which is a standard practice within the memecoin sector. The coin's narrative is heavily influenced by prominent crypto personalities, most notably Ansem, who was a key figure in the project's early viral growth and subsequent marketing initiatives. Regarding integrations, WIF has deep liquidity across major Solana decentralized exchanges like Jupiter and Raydium, is available on the Unichain network via official contract bridging, and is listed on major centralized exchanges including Binance, Coinbase, Kraken, and Bybit.  WIF is a purely speculative asset whose value is primarily driven by community sentiment and meme culture rather than traditional utility. It was launched without a presale or significant venture capital allocation, meaning the token's supply is fully circulating. The project has achieved a "blue chip" status in the memecoin space, often serving as a beta-play for the broader health of the Solana ecosystem. No native decentralized applications or trading bots have been officially launched by the core team, as the project maintains its focus on its identity as "literally a dog wif a hat".

dogwifhat

Dogwifhat ($WIF) is facing heightened scrutiny as the community remains sharply divided, with some investors betting on a potential uptrend from current levels while others express intense frustration over persistent price stagnation and frequent pullbacks. Market participants are actively debating the token's long-term utility versus its status as a meme-driven asset, creating a volatile environment marked by speculative price predictions and concerns over fading interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM Test-GUIDED CARE

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM Test-GUIDED CARE PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM Test-GUIDED CARE PR Newswire SALT LAKE CITY, July 9, 2026...

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS PR Newswire SALT LAKE CITY, June 30, 2026 SALT LAKE CITY, June 30, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company...

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH PR Newswire SALT LAKE CITY, June 24, 2026 SALT LAKE CITY, June 24, 2026 /PRNewswire/ -- Sera...

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY PR Newswire SALT LAKE CITY, June 23, 2026 --Aligns With Growing Focus on Early Identification...

All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy

Sera Prognostics (SERA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION PR Newswire SALT LAKE CITY, June 1, 2026 SALT LAKE CITY, June 1, 2026 /PRNewswire/ --Sera Prognostics Inc., The Pregnancy Company (Nasdaq: SERA), focused on improving maternal and neonatal health by providing...

Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Sera Prognostics (SERA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Sera Prognostics (NASDAQ:SERA - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus...

Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates

Sera Prognostics (SERA) delivered earnings and revenue surprises of -6.25% and -90.35%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS PR Newswire SALT LAKE CITY, May 6, 2026 SALT LAKE CITY, May 6, 2026...

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Sera Prognostics Inc - Ordinary Shares Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.15	--	--	N/A
Q1 '26	-$0.17	-$0.17	-2.00%	MISSED
Q4 '25	-$0.19	-$0.16	15.33%	BEAT
Q3 '25	-$0.20	-$0.16	19.03%	BEAT
Q2 '25	-$0.22	-$0.16	28.89%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

SERASera Prognostics Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest SERA News